Xcout Intel
Beacon Biosignals
Beacon Biosignals is a healthtech company that uses EEG data, digital biomarkers, and machine learning to characterize brain activity and support neuroscience research and clinical drug development. It serves pharmaceutical and biotechnology companies, academic researchers, and clinical-trial teams working on neurological and psychiatric disorders.
Subscribe to see Beacon Biosignals’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Beacon Biosignals at a glance
Beacon Biosignals is a healthtech company headquartered in United States. Its most recent funding round, Series B, raised $97M in April 2026. Xcout tracks 20 named people at Beacon Biosignals, including Jacob Donoghue (CEO). Xcout recorded 96 job postings from Beacon Biosignals in the last 90 days, naming tools such as PyTorch, GitHub.
Beacon Biosignals leadership
- Jacob DonoghueCEO
- David MatthewsChief Business Officer
- Matt AlkaitisChief Clinical Officer
- Jacob DonoghueCEO & Co-Founder
- Jarrett RevelsCTO & Co-Founder
- Alex ChanVP of Analytics and Machine Learning
14 more named people on record for Beacon Biosignals, with roles, board committees and tenure — see the full roster →
Beacon Biosignals funding rounds
Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| Series B | $97M | 4 named | |
| SEC Form D filing | $103.3M | — | |
| SEC Form D filing | $29.9M | — | |
| — | Undisclosed | 4 named |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Hiring at Beacon Biosignals
Xcout recorded 96 job postings from Beacon Biosignals in the last 90 days, from a hiring record Xcout has kept since July 2026.
Tools named in Beacon Biosignals's job postings
The weekly hiring trend, the roles and locations behind it — see Beacon Biosignals's hiring signals →
Hiring vs the trend
Based on 47 job postings in the last 8 weeks (24 Aug – 18 Oct 2026), compared with 181 scale-up healthcare companies.
This describes a hiring pattern — how often Beacon Biosignals’s job postings ask for AI skills, and how that changed against the previous 8 weeks, ranked among its peers. It says nothing about the company’s products or performance.
Signed-in members see the AI-skill share and its change with peer percentiles, role mix, posting momentum and advertised US pay against the market.
Investors
Tech stack
Beacon Biosignals competitors
A few of Beacon Biosignals's closest competitors — see the full list of competitors and alternatives →
Indivi AG is a biotechnology research company headquartered in Basel, Switzerland. It focuses on pioneering the future of precision neurology through digital biomarkers for clinical research and patient monitoring, dedicated to unlocking the potential of digital measurements in drug development.
Concerto HealthAI was a healthcare technology company that used artificial intelligence and real-world data to support drug development and precision medicine. It primarily served biopharmaceutical companies, helping them generate clinical evidence and identify or stratify patients, particularly in oncology.
Cumulus Neuroscience is a UK neurotechnology company that develops wearable EEG headsets and associated software for measuring brain activity and cognitive function. Its products are intended primarily for pharmaceutical and biotechnology companies conducting clinical trials and developing treatments for neurological and psychiatric disorders.
Basil Health is a neuro-wellness technology company building platforms that track stress, focus, calm, and sleep. It combines insights from ancient wisdom, modern neuroscience, and AI-driven EEG biofeedback.
Based in Toronto, Canada, Firefly Neuroscience, Inc. is a medical technology and artificial intelligence firm specializing in developing neuroscientific solutions. The company's primary goal is to enhance patient outcomes for individuals affected by mental illnesses and neurological disorders. Its flagship product, Brain Network Analytics, is a sophisticated software platform engineered to aid in the diagnosis and treatment of a diverse range of cognitive and psychiatric conditions. These conditions encompass, but are not limited to, depression, dementia, anxiety disorders, concussions, and attention-deficit/hyperactivity disorder. Firefly Neuroscience, Inc. caters to both pharmaceutical companies and medical practitioners.
Get Beacon Biosignals's news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Something wrong or missing about Beacon Biosignals? Suggest a correction
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on Beacon Biosignals in Xcout Intel
- 20 named people with titles, LinkedIn and board committees
- 4 funding rounds with the investors in each, and who they co-invest with
- Weekly hiring history and the mix of roles behind it
- The full competitor set, tracking, exports and API access